Pajjiż: Ingilterra
Lingwa: Ingliż
Sors: VMD (Veterinary Medicines Directorate)
Cinchocaine Hydrochloride, Secobarbital Sodium
Dechra Limited
QN05CB02
Cinchocaine Hydrochloride, Secobarbital Sodium
Solution for injection
POM-V - Prescription Only Medicine – Veterinarian
Cats, Cattle, Dogs, Horses
Neurological Agent euthanasia agent
Authorized
2004-03-08
Revised: November 2022 AN: 02335/2021 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF VETERINARY MEDICINAL PRODUCT Somulose Solution for Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains: Active substances: Secobarbital Sodium (Quinalbarbitone Sodium) 400 mg Cinchocaine Hydrochloride 25 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for Injection Clear, slightly straw coloured viscous solution 4. CLINICAL PARTICULARS 4.1. TARGET SPECIES Dogs, cats, horses and cattle. 4.2. INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For euthanasia in dogs, cats, horses and cattle only. 4.3. CONTRAINDICATIONS The combination product must not be used for anaesthesia, it is non-sterile. Do not use the carcass for animal consumption due to the risk of secondary intoxication. 4.4. SPECIAL WARNINGS FOR EACH TARGET SPECIES Non-vascular administration may delay onset of effect, cause pain and result in excitement. Rarely, horses may show resistance to euthanasia and prior use of sedation should be considered in each case (see also under section 4.9). It is always advisable to have an alternative method of euthanasia available. 4.5. SPECIAL PRECAUTIONS FOR USE i) Special precautions for use in animals Care should be taken not to excite the animal. The dose is to be administered intravenously only (see also under section 4.9). Revised: November 2022 AN: 02335/2021 Page 2 of 6 It is strongly recommended that carcasses of animals euthanased with Somulose are incinerated. ii) Special precautions to be taken by the person administering the veterinary medicinal product to animals Somulose is a potent drug which is highly toxic to man. Extreme care should be taken to avoid accidental self-injection. Use an intravenous catheter instead of a needle whenever possible. Wear suitable protective gloves when handling the product. Wash off splashes from skin and eyes immediately. Wash hands after use. Due to the rapid onset of action of secobarbitone if accidentally self- administer Aqra d-dokument sħiħ